US Stock MarketDetailed Quotes

APTO Aptose Biosciences

Watchlist

1.1000
-0.0300-2.65%

Trading May 23 12:12 ET

17.94MMarket Cap-180P/E (TTM)

Aptose Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-4.08%-11.76M

-37.96%-44.59M

-7.03%-9.26M

-50.97%-10.54M

-91.61%-13.5M

-17.18%-11.3M

25.36%-32.32M

46.08%-8.65M

13.40%-6.98M

20.15%-7.05M

Net income from continuing operations

29.51%-9.64M

-22.44%-51.21M

-19.55%-11.96M

-17.08%-11.45M

-33.73%-14.13M

-19.12%-13.68M

36.01%-41.82M

58.89%-10M

13.73%-9.78M

21.57%-10.57M

Operating gains losses

--10K

----

-60.00%2K

----

385.71%20K

366.67%16K

----

350.00%5K

Depreciation and amortization

-16.79%109K

-11.74%466K

10.00%110K

-21.28%111K

-19.15%114K

-10.27%131K

-15.11%528K

-38.65%100K

-9.03%141K

-7.24%141K

Other non cash items

40.00%28K

45.36%-312K

51.11%-329K

-125.61%-21K

141.67%58K

600.00%20K

-108.19%-571K

-109.70%-673K

1,071.43%82K

115.89%24K

Change In working capital

-971.95%-3.08M

-34.91%2.81M

137.06%2.5M

-85.28%223K

-112.34%-317K

142.94%353K

184.76%4.32M

193.28%1.06M

18.36%1.52M

3.51%2.57M

-Change in prepaid assets

-3.91%246K

50.87%261K

73.72%-385K

-96.48%29K

-48.08%311K

19.63%256K

121.79%173K

-1.60%-1.47M

4.70%825K

383.06%599K

-Change in payables and accrued expense

-2,511.54%-3.14M

-32.24%2.89M

45.30%2.94M

-66.16%355K

-124.86%-528K

114.05%130K

195.98%4.27M

2,061.17%2.02M

68.92%1.05M

-9.92%2.12M

-Change in other current assets

-177.89%-74K

-176.61%-343K

-480.90%-339K

80.44%-44K

-175.00%-55K

196.88%95K

-3,000.00%-124K

4,550.00%89K

-2,350.00%-225K

---20K

-Change in other current liabilities

10.16%-115K

----

12.69%-117K

66.42%-45K

10.49%-128K

----

3.60%-134K

---134K

Cash from discontinued investing activities

Operating cash flow

-4.08%-11.76M

-37.96%-44.59M

-7.03%-9.26M

-50.97%-10.54M

-91.61%-13.5M

-17.18%-11.3M

25.36%-32.32M

46.08%-8.65M

13.40%-6.98M

20.15%-7.05M

Investing cash flow

Cash flow from continuing investing activities

32.74%-1.99M

-66.87%9.96M

-88.97%1.94M

355.08%12.95M

-119.47%-1.96M

-139.44%-2.96M

185.40%30.07M

187.82%17.57M

-2,644.86%-5.08M

101.36%10.07M

Net PPE purchase and sale

--1K

-20.83%-29K

--0

-20.83%-29K

--0

88.68%-24K

--0

---24K

Net investment purchase and sale

32.70%-1.99M

-66.80%9.99M

-88.97%1.94M

355.08%12.95M

-119.14%-1.93M

-139.44%-2.96M

185.98%30.09M

187.88%17.57M

-126,850.00%-5.08M

101.84%10.09M

Cash from discontinued investing activities

Investing cash flow

32.74%-1.99M

-66.87%9.96M

-88.97%1.94M

355.08%12.95M

-119.47%-1.96M

-139.44%-2.96M

185.40%30.07M

187.82%17.57M

-2,644.86%-5.08M

101.36%10.07M

Financing cash flow

Cash flow from continuing financing activities

23,594.00%11.85M

5,856.90%6.91M

1,574.51%854K

23,242.86%4.9M

3,706.90%1.1M

233.33%50K

-48.67%116K

-22.73%51K

21K

-65.88%29K

Net common stock issuance

34,691.18%11.83M

6,712.87%6.88M

1,554.90%844K

23,204.76%4.89M

3,724.14%1.11M

--34K

180.56%101K

41.67%51K

--21K

--29K

Proceeds from stock option exercised by employees

12.50%18K

93.33%29K

--0

--13K

--0

6.67%16K

-92.11%15K

--0

Net other financing activities

----

---5K

----

Cash from discontinued financing activities

Financing cash flow

23,594.00%11.85M

5,856.90%6.91M

1,574.51%854K

23,242.86%4.9M

3,706.90%1.1M

233.33%50K

-48.67%116K

-22.73%51K

--21K

-65.88%29K

Net cash flow

Beginning cash position

-74.97%9.25M

-5.48%36.97M

-43.84%15.72M

-79.02%8.4M

-38.47%22.76M

-5.48%36.97M

-66.68%39.11M

-62.73%27.99M

-51.96%40.03M

-57.52%36.99M

Current changes in cash

86.58%-1.91M

-1,195.33%-27.72M

-172.07%-6.47M

160.81%7.32M

-571.10%-14.36M

-568.80%-14.21M

97.27%-2.14M

124.93%8.97M

-46.00%-12.04M

181.48%3.05M

Effect of exchange rate changes

-75.00%1K

150.00%2K

-116.67%-1K

114.29%1K

40.00%-3K

100.00%4K

-157.14%-4K

-14.29%6K

-75.00%-7K

-600.00%-5K

End cash Position

-67.73%7.35M

-74.97%9.25M

-43.84%15.72M

-79.02%8.4M

-38.47%22.76M

-5.48%36.97M

-62.73%27.99M

-51.96%40.03M

Free cash flow

-4.08%-11.76M

-37.94%-44.62M

-7.03%-9.26M

-50.97%-10.54M

-91.37%-13.53M

-17.18%-11.3M

25.67%-32.35M

46.13%-8.65M

15.30%-6.98M

19.88%-7.07M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-4.08%-11.76M	-37.96%-44.59M	-7.03%-9.26M	-50.97%-10.54M	-91.61%-13.5M	-17.18%-11.3M	25.36%-32.32M	46.08%-8.65M	13.40%-6.98M	20.15%-7.05M
Net income from continuing operations	29.51%-9.64M	-22.44%-51.21M	-19.55%-11.96M	-17.08%-11.45M	-33.73%-14.13M	-19.12%-13.68M	36.01%-41.82M	58.89%-10M	13.73%-9.78M	21.57%-10.57M
Operating gains losses	--10K	----	----	----	-60.00%2K	----	385.71%20K	366.67%16K	----	350.00%5K
Depreciation and amortization	-16.79%109K	-11.74%466K	10.00%110K	-21.28%111K	-19.15%114K	-10.27%131K	-15.11%528K	-38.65%100K	-9.03%141K	-7.24%141K
Other non cash items	40.00%28K	45.36%-312K	51.11%-329K	-125.61%-21K	141.67%58K	600.00%20K	-108.19%-571K	-109.70%-673K	1,071.43%82K	115.89%24K
Change In working capital	-971.95%-3.08M	-34.91%2.81M	137.06%2.5M	-85.28%223K	-112.34%-317K	142.94%353K	184.76%4.32M	193.28%1.06M	18.36%1.52M	3.51%2.57M
-Change in prepaid assets	-3.91%246K	50.87%261K	73.72%-385K	-96.48%29K	-48.08%311K	19.63%256K	121.79%173K	-1.60%-1.47M	4.70%825K	383.06%599K
-Change in payables and accrued expense	-2,511.54%-3.14M	-32.24%2.89M	45.30%2.94M	-66.16%355K	-124.86%-528K	114.05%130K	195.98%4.27M	2,061.17%2.02M	68.92%1.05M	-9.92%2.12M
-Change in other current assets	-177.89%-74K	-176.61%-343K	-480.90%-339K	80.44%-44K	-175.00%-55K	196.88%95K	-3,000.00%-124K	4,550.00%89K	-2,350.00%-225K	---20K
-Change in other current liabilities	10.16%-115K	----	----	12.69%-117K	66.42%-45K	10.49%-128K	----	----	3.60%-134K	---134K
Cash from discontinued investing activities
Operating cash flow	-4.08%-11.76M	-37.96%-44.59M	-7.03%-9.26M	-50.97%-10.54M	-91.61%-13.5M	-17.18%-11.3M	25.36%-32.32M	46.08%-8.65M	13.40%-6.98M	20.15%-7.05M
Investing cash flow
Cash flow from continuing investing activities	32.74%-1.99M	-66.87%9.96M	-88.97%1.94M	355.08%12.95M	-119.47%-1.96M	-139.44%-2.96M	185.40%30.07M	187.82%17.57M	-2,644.86%-5.08M	101.36%10.07M
Net PPE purchase and sale	--1K	-20.83%-29K	--0	--0	-20.83%-29K	--0	88.68%-24K	--0	--0	---24K
Net investment purchase and sale	32.70%-1.99M	-66.80%9.99M	-88.97%1.94M	355.08%12.95M	-119.14%-1.93M	-139.44%-2.96M	185.98%30.09M	187.88%17.57M	-126,850.00%-5.08M	101.84%10.09M
Cash from discontinued investing activities
Investing cash flow	32.74%-1.99M	-66.87%9.96M	-88.97%1.94M	355.08%12.95M	-119.47%-1.96M	-139.44%-2.96M	185.40%30.07M	187.82%17.57M	-2,644.86%-5.08M	101.36%10.07M
Financing cash flow
Cash flow from continuing financing activities	23,594.00%11.85M	5,856.90%6.91M	1,574.51%854K	23,242.86%4.9M	3,706.90%1.1M	233.33%50K	-48.67%116K	-22.73%51K	21K	-65.88%29K
Net common stock issuance	34,691.18%11.83M	6,712.87%6.88M	1,554.90%844K	23,204.76%4.89M	3,724.14%1.11M	--34K	180.56%101K	41.67%51K	--21K	--29K
Proceeds from stock option exercised by employees	12.50%18K	93.33%29K	--0	--13K	--0	6.67%16K	-92.11%15K	--0	--0	--0
Net other financing activities	----	----	----	---5K	---5K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	23,594.00%11.85M	5,856.90%6.91M	1,574.51%854K	23,242.86%4.9M	3,706.90%1.1M	233.33%50K	-48.67%116K	-22.73%51K	--21K	-65.88%29K
Net cash flow
Beginning cash position	-74.97%9.25M	-5.48%36.97M	-43.84%15.72M	-79.02%8.4M	-38.47%22.76M	-5.48%36.97M	-66.68%39.11M	-62.73%27.99M	-51.96%40.03M	-57.52%36.99M
Current changes in cash	86.58%-1.91M	-1,195.33%-27.72M	-172.07%-6.47M	160.81%7.32M	-571.10%-14.36M	-568.80%-14.21M	97.27%-2.14M	124.93%8.97M	-46.00%-12.04M	181.48%3.05M
Effect of exchange rate changes	-75.00%1K	150.00%2K	-116.67%-1K	114.29%1K	40.00%-3K	100.00%4K	-157.14%-4K	-14.29%6K	-75.00%-7K	-600.00%-5K
End cash Position	-67.73%7.35M	-74.97%9.25M	-74.97%9.25M	-43.84%15.72M	-79.02%8.4M	-38.47%22.76M	-5.48%36.97M	-5.48%36.97M	-62.73%27.99M	-51.96%40.03M
Free cash flow	-4.08%-11.76M	-37.94%-44.62M	-7.03%-9.26M	-50.97%-10.54M	-91.37%-13.53M	-17.18%-11.3M	25.67%-32.35M	46.13%-8.65M	15.30%-6.98M	19.88%-7.07M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall